ranimustine has been researched along with Multiple Myeloma in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 6 (30.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagiwara, S; Hinoshita, F; Hoshino, T; Inoue, T; Katagiri, D; Katsuma, A; Masumoto, S; Minami, E; Nakamura, T; Shibata, M; Shimbo, T; Tada, M | 1 |
| Chou, T; Deura, K; Hirano, M; Hotta, T; Itoh, K; Kawano, K; Konda, S; Matsuda, S; Mikuni, C; Mizorogi, F; Nagoshi, H; Ohno, T; Sai, T; Sano, M; Shimoyama, M; Suzuki, T; Takenaka, T; Tomonaga, M; Tsushita, K; Utsunomiya, A; Yamada, T | 1 |
| Kusaba, N; Mishima, K; Ohkubo, F; Okamura, T; Sata, M; Shimamastu, K; Yoshida, H | 1 |
| Fujimoto, Y; Ishihara, S; Izumi, H; Kaneko, K; Kato, M; Kuraishi, Y; Nagase, D; Natori, K; Umeda, M | 1 |
| Handa, H; Jinbo, T; Karasawa, M; Matsumoto, M; Matsushima, T; Morita, K; Murakami, H; Murayaman, K; Nojima, Y; Ogawara, H; Sawamura, M; Shimano, S; Tsukamoto, N; Uchiumi, H; Yamane, A; Yokohama, A | 1 |
| Fujimoto, N; Fujita, S; Fujitake, H; Harashima, S; Hirata, M; Hirota, Y; Horiuchi, A; Hoshino, A; Kamiya, O; Kanamaru, R; Kanayama, Y; Katoh, Y; Kawagoe, H; Kimura, K; Kitani, T; Kojima, T; Konda, C; Masaoka, T; Matsubuchi, T; Miyazaki, T; Morioka, M; Musashi, M; Nagai, K; Nagata, K; Nakamura, T; Nakao, I; Oguro, M; Ohara, K; Ohhashi, Y; Ohkubo, A; Ohno, R; Okamoto, Y; Saitoh, H; Saitoh, T; Sakai, Y; Sakurada, K; Sasada, M; Sasaki, T; Shibata, H; Takada, T; Takagi, T; Takubo, T; Taniguchi, N; Tsubaki, K; Tsubakio, T; Wakui, A; Yamada, K; Yasunaga, K; Yokoyama, M; Yonezawa, T | 1 |
| Togawa, A | 1 |
| Kitani, T | 1 |
| Hirabayashi, N; Hotta, T; Ichikawa, A; Kamiya, O; Kato, R; Kato, Y; Kawashima, K; Kobayashi, M; Mizuno, H; Nagura, E; Naito, K; Nishiwaki, H; Nitta, M; Saito, H; Shibata, T; Shimizu, K; Takeyama, H; Tanaka, M; Utsumi, M | 1 |
| Hamajima, N; Kawamura, T; Kitani, T; Kuriya, SI; Maekawa, I; Miyazaki, T; Mizoguchi, H; Niho, Y; Ohno, R; Sato, Y; Shibata, A; Shimazaki, C; Taguchi, H; Wada, M | 1 |
| Fujieda, A; Ichioka, M; Miyanishi, E; Miyashita, H; Tamaki, S; Tanaka, K; Tanigawa, M; Taniguchi, M; Tsuji, K | 1 |
| Imai, K; Kawamura, T; Kondo, K; Sakurai, H; Sato, T; Takemori, N | 1 |
| Hiramori, K; Kowada, S; Masuda, T; Nakamura, M; Sato, F; Satoh, H; Satoh, M; Tashiro, A | 1 |
| Ichikawa, A; Kamiya, O; Kawashima, K; Kobayashi, M; Mizuno, H; Nagura, E; Nitta, M; Saito, H; Shimizu, K; Takeyama, H; Wakita, A; Yamao, H | 1 |
| Asaoku, H; Ishikawa, H; Iwato, K; Kawano, M; Kuramoto, A; Nobuyoshi, M; Sakai, A; Tanabe, O; Tanaka, H | 1 |
| Hino, N; Kawakami, K; Matsumoto, T; Matsuura, W; Ono, T; Tominaga, T | 1 |
| Ito, T; Saito, Y; Uzuka, Y | 1 |
| Kanoh, T; Ohnaka, T; Ohno, T; Uchino, H | 1 |
| Ikeda, Y; Kobayashi, M; Kobayashi, T; Ohno, R; Ohta, K; Shirakawa, S; Tanaka, I; Yamada, H; Yamada, K; Yamagata, K | 1 |
| Higuchi, A; Imamura, M; Kasai, M; Maekawa, I; Miyazaki, T; Morioka, M; Musashi, M; Ohtani, N; Saitoh, H; Sakurada, K | 1 |
1 review(s) available for ranimustine and Multiple Myeloma
| Article | Year |
|---|---|
[Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Diagnosis, Differential; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Neutrophilic, Chronic; Leukocytosis; Male; Melphalan; Multiple Myeloma; Neutrophils; Nitrosourea Compounds; Treatment Outcome; Vincristine | 2004 |
5 trial(s) available for ranimustine and Multiple Myeloma
| Article | Year |
|---|---|
Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Japan; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisone; Treatment Outcome; Vincristine | 2004 |
[Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Humans; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds | 1983 |
[New protocols for myeloma chemotherapy plus IFN alpha].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Administration Schedule; Humans; Interferon-alpha; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Pilot Projects; Remission Induction; Survival Rate; Vincristine | 1993 |
A randomized study comparing VMCP and MMPP in the treatment of multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prednisone; Procarbazine; Vincristine | 1997 |
Induction therapy consisting of alternating cycles of ranimustine, vincristine, melphalan, dexamethasone and interferon alpha (ROAD-IN) and a randomized comparison of interferon alpha maintenance in multiple myeloma: a co-operative study in Japan.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Connectin; Dexamethasone; Humans; Interferon-alpha; Logistic Models; Melphalan; Multiple Myeloma; Muscle Proteins; Myeloma Proteins; Nitrosourea Compounds; Pilot Projects; Prospective Studies; Remission Induction; Vincristine | 2000 |
14 other study(ies) available for ranimustine and Multiple Myeloma
| Article | Year |
|---|---|
Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis.
Topics: Acute Kidney Injury; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Biomarkers; Calcium; Creatinine; Dexamethasone; Doxorubicin; Female; Humans; Kidney; Male; Melphalan; Middle Aged; Multiple Myeloma; Multivariate Analysis; Nitrosourea Compounds; Prednisolone; Prognosis; Recovery of Function; Renal Dialysis; Survival Analysis; Treatment Outcome; Vincristine | 2011 |
[Four cases of therapy-related leukemia in multiple myeloma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Nitrosourea Compounds; Prednisolone; Prednisone; Vincristine | 2007 |
Combination chemotherapy of ranimustine, doxorubicine, and dexamethasone for relapsing multiple myeloma--a pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Doxorubicin; Humans; Multiple Myeloma; Nitrosourea Compounds; Pilot Projects | 2003 |
[Recent therapy for refractory myeloma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Podophyllotoxin; Prednisone; Remission Induction; Survival Rate; Vincristine | 1993 |
[Aggressive transformation and extramedullary tumor formation in IgA-lambda multiple myeloma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Dexamethasone; Female; Humans; Immunoglobulin A; Immunoglobulin lambda-Chains; Interferon-alpha; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Vincristine | 2000 |
Satisfactory remission in a case of IgD myeloma: effectiveness of glucocorticoid treatment.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Female; Glucocorticoids; Humans; Immunoglobulin D; Immunoglobulin lambda-Chains; Interferons; Melphalan; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Nitrosourea Compounds; Prednisolone; Remission Induction; Vincristine | 2001 |
Reversible restrictive cardiomyopathy due to light-chain deposition disease.
Topics: Adult; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow Examination; Cardiomyopathy, Restrictive; Dyspnea; Echocardiography; Electrocardiography; Hemodynamics; Humans; Immunoglobulin Light Chains; Male; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Prognosis; Remission Induction; Treatment Outcome; Vincristine | 2002 |
Superior efficacy of MMCP regimen compared with VMCP and MMPP regimens in the treatment of multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2002 |
[Study on the therapy of multiple myelomas--initial induction therapy (MP, IFN alpha, steroid pulse) and maintenance therapy (VMP, MP continuous, VEP, MCNU)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Remission Induction; Vincristine | 1992 |
[Combination chemotherapy of MCNU and interferon alfa-2a (genetical recombination) for advanced multiple myeloma].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Recombinant Proteins | 1990 |
[Combination chemotherapy of multiple myeloma].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Drug Evaluation; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Procarbazine; Remission Induction; Survival Rate | 1990 |
[Effect of MCNU on growth kinetics of human plasma cell lines--in comparison with melphalan].
Topics: Antineoplastic Agents; Cell Cycle; Cell Division; Cell Line; Humans; Melphalan; Multiple Myeloma; Nitrosourea Compounds; Tumor Cells, Cultured | 1987 |
[Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Marrow; Child; Drug Evaluation; Female; Hematologic Diseases; Humans; Leukemia; Leukemia, Myeloid; Lung Neoplasms; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia Vera; Stomach Neoplasms; Thrombocytopenia | 1985 |
[Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Lymphoma; Male; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Polycythemia | 1985 |